Anavex Life Sciences Corp (AVXL)

[georgejjl]

43 sites currently recruiting and less than 36 subjects remaining to be recruited for the Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy Trial of ANAVEX2-73 for the Treatment of Early Alzheimer's Disease (AD).

https://clinicaltrials.gov/ct2/show/NCT03790709

Good luck and GOD bless,